ClinConnect ClinConnect Logo
Search / Trial NCT01220791

Methylprednisolone Addition in IVF Treatment of Infertile Couples

Launched by UNIVERSITAIR ZIEKENHUIS BRUSSEL · Oct 13, 2010

Trial Information

Current as of May 27, 2025

Unknown status

Keywords

Methylprednisolone Ivf Progesterone Corticosteroid Late Follicular Phase Pregnancy Rates

ClinConnect Summary

The aim is to investigate any potential advantages of adding cortisone supplementation from the follicular phase onwards with regard to premature luteinization, oocyte quality, embryo quality and pregnancy outcome.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • less than 36, more than 10 antral follicles, FSH\<12
  • Exclusion Criteria:
  • endometriosis stage III\&IV,

About Universitair Ziekenhuis Brussel

Universitair Ziekenhuis Brussel (UZ Brussel) is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution affiliated with the Vrije Universiteit Brussel, UZ Brussel integrates cutting-edge medical research with high-quality patient care. The hospital's multidisciplinary teams are dedicated to exploring novel therapeutic approaches and contributing to the development of evidence-based treatments, ensuring the highest standards of safety and efficacy in clinical research. With a strong focus on collaboration and knowledge dissemination, UZ Brussel plays a pivotal role in shaping the future of medicine and improving patient outcomes.

Locations

Thessaloniki, Pylaia, Greece

Patients applied

0 patients applied

Trial Officials

Basil Tarlatzis, Professor

Study Chair

BioGenesis

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials